Annuncio • Apr 28
S.C. Ropharma S.A. to Report Fiscal Year 2025 Results on Apr 28, 2026 S.C. Ropharma S.A. announced that they will report fiscal year 2025 results on Apr 28, 2026 Annuncio • Mar 27
S.C. Ropharma S.A., Annual General Meeting, Apr 27, 2026 S.C. Ropharma S.A., Annual General Meeting, Apr 27, 2026, at 12:00 E. Europe Standard Time. Location: company s headquarters in brasov, 55, iuliu maniu street, Romania New Risk • Jan 01
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 27% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 31% per year over the past 5 years. Minor Risks Large one-off items impacting financial results. Market cap is less than US$100m (RON92.0m market cap, or US$21.2m). Reported Earnings • Dec 27
Third quarter 2025 earnings released Third quarter 2025 results: Revenue: RON392.9m (up 12% from 3Q 2024). Net income: RON3.93m (up 429% from 3Q 2024). Profit margin: 1.0% (up from 0.2% in 3Q 2024). The increase in margin was driven by higher revenue. New Risk • Sep 16
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 38% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 27% per year over the past 5 years. Minor Risks Large one-off items impacting financial results. Market cap is less than US$100m (RON91.0m market cap, or US$21.3m). New Risk • May 09
New major risk - Financial position The company's debt is not well covered by operating cash flow. Operating cash flow to total debt ratio: 7.6% This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (7.6% operating cash flow to total debt). Earnings have declined by 15% per year over the past 5 years. Minor Risk Market cap is less than US$100m (RON78.2m market cap, or US$17.2m). Reported Earnings • May 09
Full year 2024 earnings released Full year 2024 results: Revenue: RON1.33b (up 19% from FY 2023). Net loss: RON1.73m (down 122% from profit in FY 2023). Annuncio • Mar 27
S.C. Ropharma S.A., Annual General Meeting, Apr 28, 2025 S.C. Ropharma S.A., Annual General Meeting, Apr 28, 2025, at 12:30 E. Europe Standard Time. Location: at st. constantine hospital conference room in, brasov, 318 calea bucuresti, Romania New Risk • Mar 18
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 2.9% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). Share price has been volatile over the past 3 months (6.6% average weekly change). Profit margins are more than 30% lower than last year (0.003% net profit margin). Market cap is less than US$100m (RON79.2m market cap, or US$17.4m). New Risk • Feb 28
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Romanian stocks, typically moving 7.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 2.9% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (7.2% average weekly change). Profit margins are more than 30% lower than last year (0.003% net profit margin). Market cap is less than US$100m (RON81.8m market cap, or US$17.1m). New Risk • Sep 06
New major risk - Revenue and earnings growth Earnings have declined by 2.9% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 2.9% per year over the past 5 years. Minor Risks Profit margins are more than 30% lower than last year (0.003% net profit margin). Market cap is less than US$100m (RON91.5m market cap, or US$20.4m). New Risk • Mar 18
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Large one-off items impacting financial results. Market cap is less than US$100m (RON97.7m market cap, or US$21.4m). Board Change • Nov 16
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 5 highly experienced directors. No independent directors (7 non-independent directors). Member of the Board of Directors Ovidiu Nut was the last director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Board Change • Apr 27
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 5 highly experienced directors. No independent directors (7 non-independent directors). Member of the Board of Directors Ovidiu Nut was the last director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Price Target Changed • Jul 26
Price target decreased to RON0.23 Down from RON0.38, the current price target is provided by 1 analyst. New target price is approximately in line with last closing price of RON0.22. Stock is down 7.5% over the past year. Is New 90 Day High Low • Feb 09
New 90-day high: RON0.24 The company is up 6.0% from its price of RON0.22 on 11 November 2020. The Romanian market is up 17% over the last 90 days, indicating the company underperformed over that time. However, its price trend is similar to the Consumer Retailing industry, which is also up 6.0% over the same period. Is New 90 Day High Low • Jan 14
New 90-day high: RON0.24 The company is up 8.0% from its price of RON0.22 on 15 October 2020. The Romanian market is up 16% over the last 90 days, indicating the company underperformed over that time. However, its price trend is similar to the Consumer Retailing industry, which is also up 8.0% over the same period. Is New 90 Day High Low • Dec 30
New 90-day high: RON0.24 The company is up 6.0% from its price of RON0.22 on 01 October 2020. The Romanian market is up 7.0% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Consumer Retailing industry, which is up 4.0% over the same period. Is New 90 Day High Low • Nov 16
New 90-day low: RON0.21 The company is down 11% from its price of RON0.24 on 18 August 2020. The Romanian market is flat over the last 90 days, indicating the company underperformed over that time. It also underperformed the Consumer Retailing industry, which is down 2.0% over the same period. Is New 90 Day High Low • Oct 29
New 90-day low: RON0.21 The company is down 11% from its price of RON0.24 on 30 July 2020. The Romanian market is up 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Consumer Retailing industry, which is down 2.0% over the same period. Reported Earnings • Oct 09
First half earnings released Over the last 12 months the company has reported total profits of RON5.44m, down 40% from the prior year. Total revenue was RON768.4m over the last 12 months, largely unchanged from the prior year. Is New 90 Day High Low • Oct 08
New 90-day low: RON0.22 The company is down 24% from its price of RON0.29 on 09 July 2020. The Romanian market is up 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Consumer Retailing industry, which is up 3.0% over the same period. Is New 90 Day High Low • Sep 29
New 90-day low: RON0.22 The company is down 23% from its price of RON0.29 on 26 June 2020. The Romanian market is up 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Consumer Retailing industry, which is up 2.0% over the same period. 
